L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM

European Journal of Pharmacology

Volumn 326, Issue 2-3, 1997, Pages 127-132

  Hutson, Peter H ^a   Barton, Cheryl L ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Agonist, inverse; Benzodiazepine GABA(A) receptor agonist; Glycine NMDA receptor antagonist; Mesocortical dopamine neuron; Stress

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; BENZODIAZEPINE RECEPTOR; DIAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ZOLPIDEM;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRESS;

EID: 0030987259     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)85406-4     Document Type: Article

References (35)

1. Bebbington P., Wilkins S., Jones P., Foerster A., Murray R., Toone B., Lewis S. Life events and psychosis: initial results from the Camberwell Collaborative Psychosis Study. Br. J. Psychiatry. 162:1993;72-79.
2. Bradberry C.W., Lory J.D., Roth R.H. The anxiogenic β-carboline FG7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J. Neurochem. 56:1991;748-752.
3. Bristow L.J., Hutson P.H., Thorn L., Tricklebank M.D. The glycine/NMDA receptor antagonist R-(+)-HA-966 blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK801) in rodents. Br. J. Pharmacol. 108:1993;1156-1163.
4. Bristow L.J., Flatman K.L., Young L., Thorn L., Hutson P.H., Tricklebank M.D. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist L-701,324 in rodents. J. Pharmacol. Exp. Ther. 277:1996;578-585.
5. Bristow L.J., Hutson P.H., Kulagowski J.J., Ieeson P.D., Matheson S., Murray F., Rathbone D., Saywell K.L., Thorn L., Watt A., Tricklebank M.D. The anticonvulsant and behavioural profile of L-701,324 a potent orally active antagonist at the glycine modulatory site at the N-methyl-D-aspartate (NMDA) receptor complex. J. Pharmacol. Exp. Ther. 279:1996;492-501.
6. Claustre Y., Rivy J.P., Dennis T., Scatton B. Pharmacological studies on stress induced increase in frontal cortical dopamine metabolism in the rat. J. Pharmacol. Exp. Ther. 238:1986;693-700.
7. Corbett R.W., Dunn R.W. Effects of HA-966 on conflict, social interaction and plus maze behaviours. Drug Dev. Res. 24:1991;201-205.
8. Corda M.G., Blaker W.D., Mendelson W.B., Guidotti A., Costa E. β-Carbolines enhance shock induced suppression of drinking in rats. Proc. Natl. Acad. Sci. USA. 80:1983;2072-2078.
9. Crawley J.N., Ninan P.T., Pickar D., Chrousos G.P., Linoila M., Skolnick P., Paul S.M. Neuropharmacological antagonisim of the β-carboline induced anxiety response in rhesus monkeys. J. Neurosci. 5:1985;477-485.
10. Davies M., Hitchcock J.M., Bowers M.B., Berridge C.W., Melia K.R., Roth R.H. Stress induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Res. 664:1994;207-210.
11. Deutch, A.J., Roth, R.H., 1990. The determinants of stress induced activation of the prefrontal cortical dopamine system. In: Uylings, H.B.M., VanEden, C.G., DeBruin, J.P.C., Corner, M.A., Feenstra, M.G.P. (Eds.), Progress in Brain Research. Elsevier, Amsterdam, pp. 367-402.
12. Dohrenwend B.P., Egri G. Recent stressful life events and episodes of schizophrenia. Schizophr. Bull. 7:1981;12-23.
13. Dunn R.W., Flanagan D.M., Martin L.L., Kerman L.L., Woods A.T., Camacho F., Wilmot C.A., Cornfeldt M.L., Effland R.C., Wood P.L., Corbett R. Stereoselective R(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur. J. Pharmacol. 214:1992;207-214.
14. Fadda F., Argiolas A., Melis M.R., Tissari A.H., Onali P.L., Gessa G.L. Stress induced increase in 3,4 dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in nucleus accumbens: reversal by diazepam. Life Sci. 23:1978;2219-2224.
15. Faiman C.P., Viu E., Skolnick P., Trullas R. Differential effects of compounds that act at strychnine insensitive glycine receptors in a punishment procedure. J. Pharmacol. Exp. Ther. 270:1994;528-533.
16. Feenstra M.G.P., Blotterblom M.H., Van Uum J.F.M. Novelty induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam. Neurosci. Lett. 189:1995;81-84.
17. File S.E., Pellow S., Braestrup C. Effects of the β-carboline FG7142 in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrations. Pharmacol. Biochem. Behav. 22:1985;941-944.
18. Giorgio O., Corda M.G., Biggio G. The anxiolytic β-carboline ZK 93423 prevents the stress induced increase in dopamine turnover in the prefrontal cortex. Eur. J. Pharmacol. 134:1987;327-331.
19. Herman J.P., Guillonneau R., Dantzer D., Scatton R.B., Semerdjian L., LeMoal M. Differential effects of inescapable footshocks and stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:1982;2207-2214.
20. Hutson P.H., Bristow L.J., Thorn L., Tricklebank M.D. R-(+)-HA-966 a glycine/NMDA receptor antagonist attenuates activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103:1991;2037-2044.
21. Hutson P.H., Thorn L., Bristow L.J., Tricklebank M.D. L-701,324 a glycine/NMDA receptor antagonist attenuates activation of the mesolimbic dopamine system by phencyclidine. Br. J. Pharmacol. 114:1995;322.
22. Ida Y., Tsuda A., Sueyoshi K., Shirao I., Tanaka M. Blockade by diazepam of conditioned fear induced activation of rat mesoprefrontal dopamine neurones. Pharmacol. Biochem. Behav. 33:1989;477-479.
23. Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther. 251:1989;378-387.
24. Kaneyuki H., Yokoo H., Tsuda A., Yoshida Y., Mizuki M.Y., Yamada M., Tanaka M. Psychological stress increases dopamine turnover selectively in mesoprefrontal dopamine neurones of rats: reversal by diazepam. Brain Res. 557:1991;154-161.
25. Kehne J.H., McCloskey T.C., Baron B.M., Chi E.M., Harrison B.L., Whitton J.P., Palfryman M.G. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation induced ultrasonic vocalisations. Eur. J. Pharmacol. 193:1991;283-292.
26. Kulagowski J.J., Baker R., Curtis N.R., Leeson P.D., Mawer I.M., Mosely A.M., Ridgill M.P., Rowley M., Stansfield I., Foster A.C., Grimwood S., Hill R.G., Kemp J.A., Marshall G.R., Saywell K.L., Tricklebank M.D. 3′-(arylmethyl)- and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2-(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem. 37:1994;1402-1405.
27. Lavielle S., Tassin J.P., Thierry A.M., Blanc G., Herve D., Barthelemy C., Glowinski J. Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurones of the rat. Brain Res. 168:1978;585-594.
28. Morrow B.A., Clark W.A., Roth R.H. Stress activation of mesocorticolimbic neurons: effects of a glycine/NMDA receptor antagonist. Eur. J. Pharmacol. 238:1993;255-262.
29. Priestley T., Danks P., Marshall G.R., Kemp J.A., Kulagowski J.J., Leeson P.D., Hill R.G. L-701,324: a high affinity antagonist at the glycine recognition site of the NMDA receptor. Br. J. Pharmacol. 113:1994;31.
30. Reinhard J.F., Bannon M.J., Roth R.H. Accelaration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam. Naunyn-Schmiedeberg's Arch. Pharmacol. 318:1982;374-377.
31. Singh L., Donald A.E., Foster A.C., Hutson P.H., Iversen L.L., Iversen S.D., Kemp J.A., Leeson P.D., Marshall G.R., Oles R.J., Priestley T., Thorn L., Tricklebank M.D., Vass C.A., Williams B.J. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist but (-)-HA-966 is a potent γ-butyrolactone like sedative. Proc. Natl. Acad. Sci. USA. 87:1990;347-351.
32. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 59:1993;695-703.
33. Tam S.Y., Roth R.H. Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta carboline FG 7142. Biochem. Pharmacol. 34:1985;1594-1598.
34. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of the mesocortical DA system by stress. Nature. 263:1976;242-244.
35. Trullas R., Jackson B., Skolnick P. Anxiolytic properties of 1-aminocyclopropanecarboxylic acid a ligand at strychnine insensitive glycine receptors. Pharmacol. Biochem. Behav. 34:1989;313-316.